000 01345 a2200385 4500
005 20250513120007.0
264 0 _c19970522
008 199705s 0 0 eng d
022 _a1553-0841
024 7 _a10.1902/annals.1997.2.1.259
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGraves, D T
245 0 0 _aThe use of biologic response modifiers in human clinical trials.
_h[electronic resource]
260 _bAnnals of periodontology
_cMar 1997
300 _a259-67 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBone Morphogenetic Proteins
650 0 4 _aClinical Trials as Topic
_xmethods
650 0 4 _aDrug Evaluation
650 0 4 _aGrowth Substances
_xtherapeutic use
650 0 4 _aGuided Tissue Regeneration, Periodontal
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aOutcome Assessment, Health Care
650 0 4 _aPatient Care Planning
650 0 4 _aPatient Selection
650 0 4 _aPeriodontal Diseases
_ximmunology
650 0 4 _aPeriodontium
_xphysiology
650 0 4 _aRegeneration
650 0 4 _aResearch Design
773 0 _tAnnals of periodontology
_gvol. 2
_gno. 1
_gp. 259-67
856 4 0 _uhttps://doi.org/10.1902/annals.1997.2.1.259
_zAvailable from publisher's website
999 _c9132857
_d9132857